Abiomed

Yes! Through Herm.io, you can unlock personalized Abiomed deals and exclusive rewards based on your shopping profile. Instead of the same generic discounts everyone gets, your profile shows Abiomed that you're a valuable shopper — and they respond with better offers. Sign up for free to see what exclusive rewards are available for you.

Abiomed offers products across the following categories: Services, Health & Wellness, Health Services. Browse their full range on their official website or explore exclusive offers for Abiomed products on Herm.io.

You can reach Abiomed through their official website at https://abiomed.com for support options.

Sign up for free on Herm.io, connect your shopping history, and follow Abiomed. Your shopping profile helps Abiomed see you're a valuable customer, unlocking personalized discounts, store credit, and exclusive merchandise. The more you engage and prove your loyalty, the better your rewards become.

Abiomed is a U.S.-based medical technology company that develops the Impella heart pump system, which is the world's smallest heart pump. Their products are minimally invasive cardiac support devices used by healthcare professionals to treat patients with severe heart disease, cardiogenic shock, and advanced heart failure. These are medical devices used in hospitals, not consumer products.

Impella is a percutaneous catheter-based heart pump that provides direct left ventricular support, whereas ECMO is an extracorporeal system requiring larger cannulas and an external pump. Compared to intra-aortic balloon pumps (IABP), Impella provides more active hemodynamic support rather than passive counterpulsation. Impella is positioned as a minimally invasive option that can provide greater cardiac output support than IABP while being less invasive than surgical ventricular assist devices.

Yes, Impella heart pumps are specifically designed for treating cardiogenic shock and are recognized in leading cardiovascular society guidelines for this indication. The devices provide hemodynamic support to stabilize patients during acute cardiac events. However, device selection and treatment decisions are made by specialized cardiovascular healthcare professionals based on individual patient conditions and clinical presentation.

Abiomed specializes in temporary percutaneous heart pumps for acute cardiac support, while Abbott and Medtronic offer broader cardiovascular portfolios including durable ventricular assist devices (VADs), pacemakers, and structural heart products. Abiomed's Impella focuses on short-term hemodynamic support during procedures or acute events, whereas Abbott's HeartMate and Medtronic's HVAD are designed for long-term heart failure management. Each company serves different clinical needs within cardiac care.

Abiomed Impella devices are available in the United States, Europe, Japan, and Asia-Pacific regions through hospital cardiac care centers. Patients cannot directly purchase or request these devices as they are prescribed and implanted by specialized cardiologists during emergency or planned cardiac procedures. The company offers a hospital finder tool on their website to locate facilities that have Impella technology available.

Abiomed Impella devices have FDA approval in the United States and CE Mark certification in Europe, meeting strict regulatory standards for cardiac medical devices. These approvals indicate the devices have undergone rigorous clinical testing and meet safety and efficacy requirements for use in treating patients with cardiogenic shock and heart failure.

Abiomed Impella devices are premium-priced hospital equipment typically costing tens of thousands of dollars per procedure, with costs covered through hospital billing rather than direct patient purchase. Medicare, Medicaid, and most major insurance plans cover medically necessary Impella procedures when performed for approved indications, though patient responsibility varies by individual policy and clinical circumstances.

SmartAssist is an automated control algorithm integrated into newer Impella models that continuously monitors patient hemodynamics and adjusts pump speed to optimize cardiac support and reduce complications. This technology provides real-time feedback to clinicians and helps maintain safe positioning and optimal performance throughout treatment.

Yes, Abiomed was acquired by Johnson & Johnson and operates as part of their medical device portfolio. The brand continues to develop and market Impella heart pumps while benefiting from Johnson & Johnson's broader resources and global reach in healthcare.

Impella devices are designed for short-term hemodynamic support, typically ranging from hours to several days depending on the specific model and clinical indication. Extended support duration decisions are made by the treating cardiologist based on patient recovery progress and hemodynamic stability.